Biogen Inc.
An insider at 1 company in coverage, as reported on Form 4. SEC CIK 875045. Latest Form 4 filed Sep 28, 2023.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Sangamo Therapeutics, IncSGMOQ | 10% owner | 12 | 2021-11-26 | 2023-09-26 |
Transactions: 12
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2023-09-26 | Sangamo Therapeutics, Inc10% owner | Sale | 6,000,000 | $0.50 | $3.0m | Form 4 |
| 2022-08-30 | Sangamo Therapeutics, Inc10% owner | Sale | 100,000 | $5.2652 | $526.5k | Form 4 |
| 2022-08-29 | Sangamo Therapeutics, Inc10% owner | Sale | 400,000 | $5.3268 | $2.1m | Form 4 |
| 2021-12-28 | Sangamo Therapeutics, Inc10% owner | Sale | 2,764 | $8.5101 | $23.5k | Form 4 |
| 2021-12-27 | Sangamo Therapeutics, Inc10% owner | Sale | 600 | $8.56 | $5.1k | Form 4 |
| 2021-12-23 | Sangamo Therapeutics, Inc10% owner | Sale | 81,187 | $8.5547 | $694.5k | Form 4 |
| 2021-12-09 | Sangamo Therapeutics, Inc10% owner | Sale | 23,660 | $8.5605 | $202.5k | Form 4 |
| 2021-12-08 | Sangamo Therapeutics, Inc10% owner | Sale | 75,814 | $8.6373 | $654.8k | Form 4 |
| 2021-12-07 | Sangamo Therapeutics, Inc10% owner | Sale | 52,178 | $8.5177 | $444.4k | Form 4 |
| 2021-12-02 | Sangamo Therapeutics, Inc10% owner | Sale | 1,874 | $8.5074 | $15.9k | Form 4 |
| 2021-12-01 | Sangamo Therapeutics, Inc10% owner | Sale | 730 | $8.5249 | $6.2k | Form 4 |
| 2021-11-26 | Sangamo Therapeutics, Inc10% owner | Sale | 28,884 | $8.6011 | $248.4k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 21:04 ET. Listed shows no prices and gives no investment advice.